GBMC requires all proposed research that involves intervention with human subjects, identifiable private data in medical records and data collection/analysis be reviewed and approved by the IRB. The IRB monitors human subject research to determine that it is conducted ethically and in compliance with federal regulations, state laws and GBMC policies and procedures.
The function of the IRB is federally-mandated and is regulated by the Department of Health and Human Services (45 CFR 46) and the Food and Drug Administration (21 CFR 50 and 56).
GBMC maintains an assurance of compliance, called a Federalwide Assurance (FWA), with the Office for Human Research Protections (OHRP) in the U.S. Department of Health and Human Services (HHS).
|FWA Number||Expiration Date|
|FWA00003849||July 25, 2022|
All Institutional Review Boards designated in an FWA must be registered with the U.S. Department Health and Human Services (HHS). The IRB at GBMC is registered with the HHS.
|Registration Number||Expiration Date|
|IRB00002961||July 7, 2023|
The GBMC IRB is comprised of highly qualified members with varying backgrounds. The membership includes a chairperson, two vice-chairpersons and representatives from the medical staff, pharmacy, legal affairs, nursing, and the community.
The IRB meets every third Monday of the month at 5:00 p.m. in the GBMC Physicians Pavilion East Conference Center. View the Meeting Dates and Submission Deadlines.
GBMC uses IRBNet for the electronic administration and management of its IRB. All research projects submitted for review by the IRB must be sent electronically through IRBNet. Paper submissions are not accepted.
If you are a GBMC affiliated researcher interested in submitting a research project to the IRB, please refer to the Institutional Review Board Menu on the left side of this screen and “IRBNet Access and Training”.
For further information, contact the IRB staff:Cathy Demmitt
Office Fax Number: 443-849-4199